¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"diagnostic imaging"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • imaging gradient
    ¿µ»ó±â¿ï±â
  • imaging modality
    ¿µ»ó±â¹ý
  • imaging parameter
    ¿µ»óÁöÇ¥, ¿µ»óº¯¼ö
  • imaging sequence
    ¿µ»ó¿¬¼â
  • multislice imaging
    ´ÙÁßÀýÆí¿µ»ó
  • multislice imaging acquisition
    ´ÙÁßÀýÆí¿µ»óȹµæ
  • magnetic resonance imaging
    ÀÚ±â°ø¸í¿µ»ó
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • phase offset multiplanar imaging
    À§»ó¿ÀÇÁ¼Â´Ù¸é¿µ»ó
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • real time imaging
    ½Ç½Ã°£¿µ»ó
  • receptor imaging
    1. ¼ö¿ëü¿µ»ó 2. ¼ö¿ëü¿µ»óÈ­
  • spin echo imaging
    ½ºÇÉ¿¡ÄÚ¿µ»ó
  • ultrasonic imaging
    ÃÊÀ½ÆÄ¿µ»ó
  • velocity imaging
    ¼Óµµ¿µ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • imaging modality
    ¿µ»ó±â¹ý
  • imaging parameter
    ¿µ»óÁöÇ¥, ¿µ»óº¯¼ö
  • imaging sequence
    ¿µ»ó¿¬¼â
  • intravoxel coherent motion imaging
    È­Àû¼Ò³»°áÁý¿îµ¿¿µ»ó
  • intravoxel incoherent motion imaging
    È­Àû¼Ò³»ºñ°áÁý¿îµ¿¿µ»ó
  • magnetic resonance imaging
    ÀÚ±â°ø¸í¿µ»ó
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • multislice imaging
    ´ÙÁßÀýÆí¿µ»ó
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • phase offset multiplannar imaging
    À§»ó¿ÀÇÁ¼Â´Ù¸é¿µ»ó
  • real time imaging
    ½Ç½Ã°£¿µ»ó
  • receptor imaging
    ¼ö¿ëü¿µ»ó, ¼ö¿ëü¿µ»óÈ­
  • spin echo imaging
    ½ºÇÉ¿¡ÄÚ¿µ»ó
  • ultrasonic imaging
    ÃÊÀ½ÆÄ¿µ»ó
  • velocity imaging
    ¼Óµµ¿µ»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • receptor imaging
    ¼ö¿ëü¿µ»ó(È­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cine cardiac magnetic resonance imaging
    ½ÉÀå ¿µÈ­ ÀÚ±â°ø¸í¿µ»ó
  • cine magnetic resonanace imaging
  • color flow imaging
    »ö Ç÷·ù ¿µ»ó
  • color flow imaging
    »öÇ÷·ù ¿µ»ó (ßäúì×µ ç±ßÀ)
  • diffusion imaging
    È®»ê ¿µ»ó
  • diffusion tensor imaging (DTI)
    È®»ê ÅÙ¼­ ¿µ»ó
  • diffusion weighted imaging (DWI)
    È®»ê °­Á¶ ¿µ»ó
  • dynamic imaging
    µ¿Àû ¿µ»ó (ÔÑîÜ ç±ßÀ)
  • dynamic imaging
    ¿ªµ¿Àû ¿µ»ó
  • echo planar imaging (EPI)
    ¿¡ÄÚ Æò¸é ¿µ»ó
  • electrocardiograpic gated magnetic resonance imaging
    ½ÉÀüµµ µ¿±â ÀÚ±â°ø¸í¿µ»ó
  • fast Fourier imaging
    °í¼Ó Fourier ¿µ»ó
  • fast imaging technique
    °í¼Ó ¿µ»ó ±â¹ý
  • fast imaging with steady state precession (FISP)
    Ç×Á¤ »óÅ ¼¼Â÷¿îµ¿À» ÀÌ¿ëÇÑ °í¼Ó ¿µ»ó
  • fast scan imaging
    °í¼Ó ½ºÄµ ¿µ»ó
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gradient refocused imaging
    °æ»çÀçÃÊÁ¡¿µ»ó
  • half Fourier imaging
    ¹ÝFourier¿µ»ó
  • hybrid imaging
    È¥¼º¿µ»ó
  • imaging
    ¿µ»ó
  • imaging gradient
    ¿µ»ó°æ»ç(ÀÚ°è)
  • imaging modality
    ¿µ»ó±â¹ý
  • imaging of STIR sequence
    STIR¿¬¼â¿µ»ó
  • imaging parameter
    ¿µ»óÁöÇ¥, ¿µ»óº¯¼ö
  • imaging procedure
    ¿µ»óÀýÂ÷
  • imaging procedure
    ¿µ»óÁø´Ü¹ý
  • imaging sequence
    ¿µ»ó¿¬¼â
  • intravoxel coherent motion [=IVCM] imaging
    º¹¼¿³»°áÁý¿îµ¿¿µ»ó
  • intravoxel incoherent motion [=IVIM] imaging
    º¹¼¿³»ºñ°áÁý¿îµ¿¿µ»ó
  • magnetic resonance imaging [=MRI]
    ÀÚ±â°ø¸í¿µ»ó
  • magnetization transfer imaging [=MTI]
    ÀÚÈ­Àü´Þ¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
B1 induced field in magnetic resonance imaging; radiofrequency magnetic field in nuclear magnetic reson...
BEI back-scattered electron imaging; biological exposure indexes; butanol-extractable iodine
CDE canine distemper encephalitis; chlordiazepoxide; color Doppler energy [imaging]; common duct explora...
CDI cell-directed inhibitor; central or chronic diabetes insipidus; Children's Depression Inventory; col...
CFI chemotactic-factor inactivator; closed-clenched fist injury; color flow imaging; complement fixation...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DSM Diagnostic and Statistical Manual
DSM III-R Diagnostic and Statistical Manual of Mental Disorders Third Edition Revised
DL Diagnostic laparoscopy
FH-RDC Family History Research Diagnostic Criteria
PDQ Personality Diagnostic Questionnaire
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • intravoxel coherent motion imaging
    º¹¼¿³» °áÁý ¿îµ¿ ¿µ»ó
  • magnetization transfer imaging
    ÀÚÈ­ Àü´Þ ¿µ»ó
  • multiecho imaging
    ´ÙÁß ¿¡ÄÚ ¿µ»ó
  • multiphase cardiac imaging
    ´ÙÁß À§»ó ½ÉÀå ¿µ»ó
  • partial echo imaging
    ºÎºÐ ¿¡ÄÚ ¿µ»ó
  • partial volume imaging
    ºÎºÐ ¿ëÀû ¿µ»ó
  • perfusion and diffusion imaging
    °ü·ù È®»ê ¿µ»ó
  • radionuclide imaging
    ¹æ»ç¼º ÇÙÁ¾ »ó
  • shock wave imaging
    Ãæ°ÝÆÄ »ó
  • spin echo intravoxel incoherent motion imaging
    ½ºÇÉ ¿¡ÄÚÈ­ Àû¼Ò³» ºñ°áÁý ¿îµ¿ ¿µ»ó¼ú
  • stop action imaging
    Á¤Áö »óÅ ¿µ»ó
  • T1 weighted FLASH imaging
    T1 °­Á¶ FLASH ¿µ»ó
  • ultrasonic imaging
    ÃÊÀ½ÆÄ ¿µ»ó
  • Zebra-stripe imaging method
    ¾ó·è¸» ¹«´Ì ¿µ»ó ¹æ¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
blood pool imaging Nuclear medicine study using a radionuclide that is confined to the vascular compartment.
(05 Mar 2000)
bone: gallium imaging <radiology> Increased activity in: active osteomyelitis (90% sensitivity: better than Tc-99m MDP), sarcoma, cellulitis, septic arthritis, rheumatoid arthritis, Paget disease, metastases (65% sensitivity: than for bone agents) see: gallium: indications
(12 Dec 1998)
bright field imaging <microscopy> An imaging mode in a transmission electron microscopy that uses only unscattered Electrons to form the image. Contrast in such an image is due entirely to mass-thickness variations in amorphous samples, and may include diffraction contrast in crystalline samples.
(05 Aug 1998)
cardiac blood pool imaging This noninvasive test uses radioactive tracers to delineate the hearts chambers and major vessels. It may be used to detect a heart attack, heart muscle function and coronary artery disease. The patient receives a radioactive tracer by injection (into a vein) and then the heart is imaged using a gamma camera. The heart is imaged before and after exercise. This test may be used to detect and evaluate atrial septal defect, dilated cardiomyopathy, congestive heart failure, cardiomyopathy, Lyme disease (secondary), mitral stenosis and superior vena cava syndrome.
(27 Sep 1997)
radionuclide imaging Process whereby a radionuclide is injected or measured (through tissue) from an external source, and a display is obtained from any one of several rectilinear scanner or gamma camera systems. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph.
(12 Dec 1998)
Magnetic Resonance Imaging A special imaging technique used to image internal stuctures of the body, particularly the soft tissues. An MRI image is often superior to a normal X-ray image.
It uses the influence of a large magnet to polarize hydrogen atoms in the tissues and then monitors the summation of the spinning energies within living cells.
Images are very clear and are particularly good for soft tissue, brain and spinal cord, joints and abdomen. These scans may be used for detecting some cancers or for following their progress.
Acronym: MRI
(11 Nov 1997)
magnetic resonance imaging, cine A type of imaging technique used primarily in the field of cardiology. By coordinating the fast gradient-echo mri sequence with retrospective ecg-gating, numerous short time frames evenly spaced in the cardiac cycle are produced. These images are laced together in a cinematic display so that wall motion of the ventricles, valve motion, and blood flow patterns in the heart and great vessels can be visualised.
(12 Dec 1998)
malignant melanoma: gallium imaging <radiology> Greater than50% sensitivity for primary and metastatic sites: 73% sensitivity if lesion is greater than 2 cm, 17% sensitivity if less than 2 cm, see: gallium: indications malignant melanoma
(12 Dec 1998)
gated blood pool imaging Radionuclide ventriculography where scintigraphic data is acquired during repeated cardiac cycles at specific times in the cycle, using an electrocardiographic synchroniser or gating device. Analysis of right ventricular function is difficult with this technique; that is best evaluated by first-pass ventriculography (ventriculography, first-pass).
(12 Dec 1998)
ratio imaging fluorescence microscopy <procedure> A method of measurement of intracellular pH or intracellular calcium levels, using a fluorescent probe molecule (see fura-2), in which the two different excitation wavelengths are used and the emitted light levels compared.
If emission at one wavelength is sensitive to the intracellular ion level and emission at the other wavelength is not, then standardisation for intracellular probe concentration, efficiency of light collection, inactivation of probe and thickness of cytoplasm can all be performed automatically.
(17 Dec 1997)
ventilation/perfusion lung imaging <radiology> See: ventilation agents, perfusion agents, Biello-Siegel criteria
(12 Dec 1998)
phantoms, imaging Devices or objects in various imaging techniques used to visualise or enhance visualization by simulating conditions encountered in the procedure. Phantoms are used very often in procedures employing or measuring x-irradiation or radioactive material to evaluate performance. Phantoms often have properties similar to human tissue. Water demonstrates absorbing properties similar to normal tissue, hence water-filled phantoms are used to map radiation levels. Phantoms are used also as teaching aids to simulate real conditions with X-ray or ultrasonic machines.
(12 Dec 1998)
myocardial infarct imaging <radiology> Tc-99m pyrophosphate (PYP) 20 mCi, peak abnormality 2-3 days, often falsely negative before 2 days, abnormal for 7-10 days, mechanism: calcium influx into ischemic cells, PYP incorporated into crystalline structure, analogous to hydroxyapatite see: nuclear cardiology
(12 Dec 1998)
myocardial perfusion imaging <radiology> (thallium scanning) thallium (Tl) 201, acts as potassium analog, dose 2.0 - 3.0 mCi at peak exercise, 4% of injected dose reaches myocardium, imaging: exercise (1-5 min), redistribution (3-4 hrs), views: anterior, LAO 45', left lateral, interpretation: normal, reversible abnormalitymost likely to be exercise-induced ischemia, nonreversible abnormalitymost likely to be prior myocardial infarction, reverse redistribution most likely to be normal areas wash out faster, lung activity most likely to be LV failure during exercise see also: dipyridamole test, nuclear cardiology
(12 Dec 1998)
hepatobiliary imaging <radiology> The hepatobiliary scan (Tc-99m DISIDA or MBF) is the initial procedure of choice to diagnose acute cholecystitis., Sensitivity 95% False negatives: acalculous cholecystitis, Specificity 95% False positives: non-fasting state, alcoholism, parenteral nutrition (TPN), acute pancreatitis, recent narcotic use, hepatocellular disease
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á